Brief: Amgen To Acquire ChemoCentryx For $4 Billion In Cash

Churchill Capital XI

04/08/2022 13:58

Aug 4 (Reuters) - ChemoCentryx Inc  CCXI.O :
    * AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH
    * CHEMOCENTRYX INC - AMGEN WILL ACQUIRE CHEMOCENTRYX FOR $52
PER
SHARE IN CASH, REPRESENTING AN ENTERPRISE VALUE OF APPROXIMATELY
$3.7 BILLION
    * CHEMOCENTRYX INC - ACQUISITION INCLUDES TAVNEOS(®)
(AVACOPAN), A
FIRST-IN-CLASS MEDICINE FOR PATIENTS WITH SERIOUS AUTOIMMUNE
DISEASE

Source text for Eikon:  ID:nPnbLYxGBa 
Further company coverage:  CCXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))